J. Mondick

发表

Plasma pharmacokinetics and tissue distribution of the breast cancer resistance protein (BCRP/ABCG2) inhibitor fumitremorgin C in SCID mice bearing T8 tumors

S. Bates, T. Garimella, D. Ross, 2005, Cancer Chemotherapy and Pharmacology.

Drug Utilization in the Pediatric Intensive Care Unit: Monitoring Prescribing Trends and Establishing Prioritization of Pharmacotherapeutic Evaluation of Critically Ill Children

M. Narayan, J. Barrett, D. Patel, 2005, Journal of clinical pharmacology.

Latent process model of the 6-minute walk test in Duchenne muscular dystrophy

M. Gastonguay, J. Mondick, Janelle L. Lennie, 2020, Journal of Pharmacokinetics and Pharmacodynamics.

Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency

J. Barrett, V. Stallings, M. Mascarenhas, 2015, Journal of clinical pharmacology.

Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1−48 months

J. Barrett, P. Adamson, C. Coté, 2009, European Journal of Clinical Pharmacology.

Population Pharmacokinetic Investigation of Actinomycin‐D in Children and Young Adults

A. Boddy, M. Cole, L. Gibiansky, 2008, Journal of clinical pharmacology.

Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity

J. French, A. Fisher, N. Serbina, 2016, Antimicrobial Agents and Chemotherapy.

Safety, Tolerability, Pharmacokinetics, and Time Course of Pharmacologic Response of the Active Metabolite of Roxifiban, XV459, a Glycoprotein IIb/IIIa Antagonist, following Oral Administration in Healthy Volunteers

W. Ebling, H. Pieniaszek, S. Sy, 2002, Journal of clinical pharmacology.

Population Pharmacokinetics of Ketorolac in Neonates and Young Infants

A. Zuppa, J. Mondick, L. Davis, 2009, American journal of therapeutics.

Population Pharmacokinetic– Pharmacodynamic Analysis to Characterize the Effect of Empagliflozin on Renal Glucose Threshold in Patients With Type 1 Diabetes Mellitus

S. Kaspers, V. Nock, M. Riggs, 2018, Journal of clinical pharmacology.

Mixed‐effects modelling to quantify the effect of empagliflozin on renal glucose reabsorption in patients with type 2 diabetes

U. Broedl, A. Sarashina, M. Riggs, 2016, Diabetes, obesity & metabolism.

Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapy

M. Narayan, J. Barrett, J. Mondick, 2008, BMC Medical Informatics Decis. Mak..

Population Pharmacokinetics of Palivizumab, a Humanized anti-RSV

G. Robbie, L. Roskos, J. Mondick, 2012 .

Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children’s oncology group

G. Rosner, J. Barrett, M. Bernstein, 2008, Cancer Chemotherapy and Pharmacology.

Animal‐to‐Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule

J. French, N. Serbina, J. Mondick, 2016, Clinical and translational science.

Population pharmacokinetics of adalimumab biosimilar adalimumab‐adbm and reference product in healthy subjects and patients with rheumatoid arthritis to assess pharmacokinetic similarity

W. Knebel, J. Mondick, Jia Kang, 2020, British journal of clinical pharmacology.

Latent process model of the 6-minute walk test in Duchenne muscular dystrophy

M. Gastonguay, J. Mondick, Janelle L. Lennie, 2020, Journal of Pharmacokinetics and Pharmacodynamics.

Population Pharmacokinetics of Milrinone in Neonates with Hypoplastic Left Heart Syndrome Undergoing Stage I Reconstruction

S. Nicolson, T. Spray, J. Gaynor, 2006, Anesthesia and analgesia.

Bayesian modeling and simulation to inform rare disease drug development early decision-making: Application to Duchenne muscular dystrophy

M. Gastonguay, J. Mondick, Janelle L. Lennie, 2021, bioRxiv.

Model-based drug development applied to oncology

Jeffrey S Barrett, J. Barrett, Manish Gupta, 2007, Expert opinion on drug discovery.

Delayed Small Bowel Transit in Children With Cystic Fibrosis and Pancreatic Insufficiency

H. Zhuang, A. Rovner, M. Mascarenhas, 2013, Journal of pediatric gastroenterology and nutrition.

Population Pharmacokinetics of Palivizumab, a Humanized Anti-Respiratory Syncytial Virus Monoclonal Antibody, in Adults and Children

G. Losonsky, G. Robbie, L. Roskos, 2012, Antimicrobial Agents and Chemotherapy.

Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults

J. Barrett, M. Bernstein, S. Blaney, 2008, Cancer Chemotherapy and Pharmacology.

Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis

J. Barrett, V. Stallings, M. Mascarenhas, 2013, International journal of clinical pharmacology and therapeutics.

Integrated Pharmacokinetic/Pharmacodynamic Model of XV459, a Potent and Specific GPIIb/IIIa Inhibitor, in Healthy Male Volunteers

W. Ebling, J. Barrett, H. Pieniaszek, 2002, Journal of clinical pharmacology.

An Informatics Approach to Assess Pediatric Pharmacotherapy: Design and Implementation of a Hospital Drug Utilization System

M. Narayan, J. Barrett, D. Patel, 2007, Journal of clinical pharmacology.

Population Pharmacokinetics of the Selective Serotonin 5-HT1A Receptor Partial Agonist Piclozotan

J. Barrett, D. Patel, C. Oo, 2009, American journal of therapeutics.

Bmc Medical Informatics and Decision Making Integration of Modeling and Simulation into Hospital-based Decision Support Systems Guiding Pediatric Pharmacotherapy

Jeffrey S. Barrett, Mahesh Narayan, John T. Mondick, 2008 .

An Informatics Approach to Assess Pediatric Pharmacotherapy: Design and Implementation of a Hospital Drug Utilization System

M. Narayan, J. Barrett, D. Patel, 2007, Journal of clinical pharmacology.